CLSD - Clearside Biomedical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLSD is currently covered by 4 analysts with an average price target of $-10.27. This is a potential upside of $-14.15 (-364.69%) from yesterday's end of day stock price of $3.88.

Clearside Biomedical's activity chart (see below) currently has 71 price targets and 85 ratings on display. The stock rating distribution of CLSD is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 97.42% with an average time for these price targets to be met of 805 days.

Highest price target for CLSD is $5, Lowest price target is $3, average price target is $4.33.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 17-Jul-2025. First documented stock forecast 14-Aug-2016.

Currently out of the existing stock ratings of CLSD, 12 are a BUY (80%), 3 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$5

$1.1 (28.21%)

$5

3 months 10 days ago
(17-Jul-2025)

20/20 (100%)

$-1.14 (-18.57%)

557

Hold

$6

3 months 10 days ago
(17-Jul-2025)

3/3 (100%)

$-8.25 (-57.89%)

243

Hold

$3

$-0.9 (-23.08%)

$3

3 months 11 days ago
(16-Jul-2025)

13/15 (86.67%)

$-6.03 (-66.78%)

495

Buy

$5

$1.1 (28.21%)

$5

5 months 12 days ago
(15-May-2025)

9/9 (100%)

$-8.18 (-62.06%)

686

Buy

$5

$1.1 (28.21%)

$5

1 years 4 months 3 days ago
(24-Jun-2024)

2/2 (100%)

$-13.75 (-73.33%)

494

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLSD (Clearside Biomedical) average time for price targets to be met?

On average it took 805 days on average for the stock forecasts to be realized with a an average price target met ratio 97.42

Which analyst has the current highest performing score on CLSD (Clearside Biomedical) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on CLSD (Clearside Biomedical)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on CLSD

Which analyst is the currently most bullish on CLSD (Clearside Biomedical)?

Zegbeh Jallah with highest potential upside - $13.1

Which analyst is the currently most reserved on CLSD (Clearside Biomedical)?

Serge Belanger with lowest potential downside - -$0.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?